| ¿µ¹® | dexamethasone | ÇÑ±Û | µ¦»ç¸ÞŸÁ¸ |
|---|---|---|---|
| ¼³¸í | ÀΰøÀûÀ¸·Î Á¦Á¶ÇÑ ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵åÀÇ ¿ªÇÒÀ» ÇÏ´Â ¾àÁ¦. ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀ̵å¶õ ºÎ½Å°ÑÁú¿¡¼ ³ª¿À´Â È£¸£¸óÀÇ ÀÏÁ¾À¸·Î Áö¹æÁú°ú ´Ü¹éÁúÀ» ºÐÇØÇÏ¿© ´çÀ» Á¦Á¶ÇÏ¿© Ç÷ÁßÀ¸·Î ³»º¸³»´Â ÀÛ¿ëÀ» ÇÏ°í ¸ö¿¡ ÀúÀåµÇ¾î ÀÖ´Â ´çÀ» Ç÷ÁßÀ¸·Î ³»º¸³»°í ¸é¿ª±â´ÉÀ» ¾ïÁ¦ÇÏ´Â ¿ªÇÒµµ Çϴ ȣ¸£¸óÀÌ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
|---|---|
| BPN | bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy |
| PLET | polymyxin, lysozyme, EDTA, and thallous acetate [in heart infusion agar] |
| VAD | venous access device; ventricular assist device; vinblastine and dexamethasone; vitamin A deficiency... |
| PB | British pharmacopeia [Pharmacopoeia Britannica]; paraffin bath; Paul-Bunnell [antibody]; periodic br... |
| OA | Ophthalmic Artery |
|---|---|
| SOV | superior ophthalmic vein |
| PB | Polymyxin B |
| PMX-B | Polymyxin B |
| PXB | Polymyxin B |
acute angle
| neomycin | <drug> Either of two aminoglycosides (B & C) produced by Streptomyces fradiae that have generalised antibiotic activity. Neomycin A (Ineamine) contains 2 deoxy 1,3 diamino inositol combined with the aminoglycoside. (18 Nov 1997) |
|---|---|
| neomycin sulfate | The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of Gram-positive and Gram-negative bacteria. (05 Mar 2000) |
| dexamethasone | <drug> Steroid analogue (glucocorticoid), used as an anti-inflammatory drug. (18 Nov 1997) |
| dexamethasone isonicotinate | <chemical> 9-fluoro-11 beta,17,21-trihydroxy-16 alpha-methyl-pregna-1,4-diene-3,20-dione-21-isonicotinate. An anti-inflammatory, antiallergic glucocorticoid that can be administered orally, by inhalation, locally, and parenterally. It may cause water and salt retention. Pharmacological action: anti-allergic agents, steroidal anti-inflammatory agents, glucocorticoids, synthetic, glucocorticoids, topical. Chemical name: Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-((4-pyridinylcarbonyl)oxy)-, (11beta,16alpha)- (12 Dec 1998) |
| dexamethasone suppression test | <endocrinology, investigation> A test that measures the response of the adrenal glands to ACTH. Dexamethasone is given to the patient and then blood cortisol levels are measured. Under normal conditions, cortisol levels should drop in response to dexamethasone. In this test one milligram of dexamethasone is administered in the morning and then the blood is drawn for analysis the following morning. Abnormal test results can indicate Cushing's syndrome. (27 Sep 1997) |
| polymyxin | <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter. Pharmacological action: antibiotics, peptide. (12 Dec 1998) |
| polymyxin acylase | <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic Registry number: EC 3.5.1.- (26 Jun 1999) |
| polymyxin b | <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. Pharmacological action: antibiotics, peptide. Chemical name: Polymyxin B (12 Dec 1998) |
| polymyxin B sulfate | An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2. (05 Mar 2000) |
| meningeal branch of ophthalmic nerve | <anatomy, nerve> See: tentorial nerve. (05 Mar 2000) |
| superior ophthalmic vein | <anatomy, vein> Begins anteriorly from the nasofrontal vein, passes along the upper part of the medial wall of the orbit, passes through the superior orbital fissure, to empty into the cavernous sinus. Synonym: vena ophthalmica superior. (05 Mar 2000) |
| inferior ophthalmic vein | <anatomy, vein> Arises from the inferior palpebral and lacrimal veins and divides into two terminal branches, one of which runs to the pterygoid plexus while the other joins the superior ophthalmic vein or empties into the cavernous sinus. Synonym: vena ophthalmica inferior. (05 Mar 2000) |
| ophthalmic | <anatomy> Pertaining to the eye. (18 Nov 1997) |
| ophthalmic acid | A tripeptide occurring in lens, similar to glutathione but differing in the replacement of cysteine by alpha-amino-n-butyric acid (i.e., in the replacement of -SH by -CH3); a potent inhibitor of glyoxalase. Compare: norophthalmic acid. (05 Mar 2000) |
| ophthalmic artery | <anatomy, artery> Artery originating from the internal carotid artery and distributing to the eye, orbit and adjacent facial structures. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|